139 related articles for article (PubMed ID: 22750260)
21. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
22. Advances in the management of epithelial ovarian cancer.
Berkenblit A; Cannistra SA
J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
[TBL] [Abstract][Full Text] [Related]
23. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
24. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
25. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal sarcomatosis.
Salti GI; Ailabouni L; Undevia S
Ann Surg Oncol; 2012 May; 19(5):1410-5. PubMed ID: 22302269
[TBL] [Abstract][Full Text] [Related]
26. The role of surgery and treatment trends in uterine sarcoma.
Benoit L; Arnould L; Cheynel N; Goui S; Collin F; Fraisse J; Cuisenier J
Eur J Surg Oncol; 2005 May; 31(4):434-42. PubMed ID: 15837053
[TBL] [Abstract][Full Text] [Related]
27. Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan.
Sagae S; Yamashita K; Ishioka S; Nishioka Y; Terasawa K; Mori M; Yamashiro K; Kanemoto T; Kudo R
Oncology; 2004; 67(1):33-9. PubMed ID: 15459493
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma.
Kushner DM; Webster KD; Belinson JL; Rybicki LA; Kennedy AW; Markman M
Gynecol Oncol; 2000 Aug; 78(2):221-7. PubMed ID: 10926807
[TBL] [Abstract][Full Text] [Related]
29. Uterine sarcoma: 14 years experience in KCCC.
Al Wakiel H; Ragheb AM; Varghese A; Juzeer A; Vashista S; Albasmy A
Gulf J Oncolog; 2008 Jul; (4):45-51. PubMed ID: 20084775
[TBL] [Abstract][Full Text] [Related]
30. Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients.
Rossi CR; Deraco M; De Simone M; Mocellin S; Pilati P; Foletto M; Cavaliere F; Kusamura S; Gronchi A; Lise M
Cancer; 2004 May; 100(9):1943-50. PubMed ID: 15112276
[TBL] [Abstract][Full Text] [Related]
31. Paclitaxel-based chemotherapy in carcinoma of the fallopian tube.
Gemignani ML; Hensley ML; Cohen R; Venkatraman E; Saigo PE; Barakat RR
Gynecol Oncol; 2001 Jan; 80(1):16-20. PubMed ID: 11136563
[TBL] [Abstract][Full Text] [Related]
32. Perioperative chemotherapy in patients undergoing pulmonary resection for metastatic soft-tissue sarcoma of the extremity : a retrospective analysis.
Canter RJ; Qin LX; Downey RJ; Brennan MF; Singer S; Maki RG
Cancer; 2007 Nov; 110(9):2050-60. PubMed ID: 17828771
[TBL] [Abstract][Full Text] [Related]
33. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
[TBL] [Abstract][Full Text] [Related]
34. Dana-Farber Cancer Institute studies in advanced sarcoma.
Antman KH; Elias A
Semin Oncol; 1990 Feb; 17(1 Suppl 2):7-15. PubMed ID: 2106162
[TBL] [Abstract][Full Text] [Related]
35. Early outcomes of soft tissue sarcomas presenting with metastases and treated with chemotherapy.
King JJ; Fayssoux RS; Lackman RD; Ogilvie CM
Am J Clin Oncol; 2009 Jun; 32(3):308-13. PubMed ID: 19433963
[TBL] [Abstract][Full Text] [Related]
36. Treatment and outcomes in adult patients with primary cardiac sarcoma: the British Columbia Cancer Agency experience.
Truong PT; Jones SO; Martens B; Alexander C; Paquette M; Joe H; Hart J; Allan SJ
Ann Surg Oncol; 2009 Dec; 16(12):3358-65. PubMed ID: 19830494
[TBL] [Abstract][Full Text] [Related]
37. Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study.
Nooij MA; Whelan J; Bramwell VH; Taminiau AT; Cannon S; Hogendoorn PC; Pringle J; Uscinska BM; Weeden S; Kirkpatrick A; Glabbeke Mv; Craft AW;
Eur J Cancer; 2005 Jan; 41(2):225-30. PubMed ID: 15661546
[TBL] [Abstract][Full Text] [Related]
38. Gynecologic Cancer InterGroup (GCIG) consensus review for high-grade undifferentiated sarcomas of the uterus.
Pautier P; Nam EJ; Provencher DM; Hamilton AL; Mangili G; Siddiqui NA; Westermann AM; Reed NS; Harter P; Ray-Coquard I
Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S73-7. PubMed ID: 25341584
[TBL] [Abstract][Full Text] [Related]
39. Management of sarcomas of the uterus.
Novetsky AP; Powell MA
Curr Opin Oncol; 2013 Sep; 25(5):546-52. PubMed ID: 23942299
[TBL] [Abstract][Full Text] [Related]
40. Management of uterine adenosarcomas with and without sarcomatous overgrowth.
Tanner EJ; Toussaint T; Leitao MM; Hensley ML; Soslow RA; Gardner GJ; Jewell EL
Gynecol Oncol; 2013 Apr; 129(1):140-4. PubMed ID: 23283300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
